A new mission for probiotics: innovative strains that work beyond the gut Probiota Global 2024, the leading event in the microbiome industry, took place in the world's design capital and addressed key topics such as the gut-lung axis, new frontiers for the use of probiotics, marketing insisghts, customization, skin health improvement, next-generation innovation, and regulatory developments.
Participation in scientific conferences such as Probiota Global 2024 (Milan) always allows to involve researchers to present and discuss the results obtained, establishing a strong connection between universities, scientific communication and companies experienced in the field. In this context, the collaboration between Research Module 2 (RM2) of the flagship project TINCARE and the company Probionova SA (Lugano) was among the topics presented and discussed during this important scientific conference. The aim was to disseminate the significant results obtained by RM2 in the experimental characterization of a new probiotic formulation, produced by Probionova, aimed at supporting neuronal functions and not only. The purpose was precisely to build a new reality in the landscape of human microbioma research and development, aiming to improve health through the development of new applications related to the world of probiotics. At the same time, these probiotics were also evaluated as application in new therapeutic areas, allowing to amplify the role of RM2, still extending the studies in collaboration with the industrial reality.
The common thread on which the research was based is the real connection between health and disease states with the gut microflora. For this reason, the study wanted to evaluate how to promote and maintain health by preserving intestinal well-being (intestinal homeostasis), through the use of probiotics.
Probionova, convinced that they can actively contribute to the development of new strategies for the well-being of the individual, supported the study by providing high-performance probiotic strains, which have been studied by RM2 in the context of healthy aging.
The survey led to the publication of an interesting article in an indexed journal, focusing on the beneficial role of probiotic supplementation with strains such as B. bifidum novaBBF7, B. longum novaBLG2 and L. paracasei TJB8, on the maintenance of cognitive function. In addition, a subsequent publication is underway, aimed at outlining the use of probiotics, to mitigate molecular factors related to depression and anxiety, which are closely related to the processes of brain aging and neurodegeneration.